Soteria

Soteria® is a revolutionary new technology that allows patients to take biopharmaceutical drugs, including monoclonal antibodies, as a simple and safe tablet or capsule.

Phloral

Phloral® is a cutting-edge technology for precise and consistent delivery to the colon. It exploits changes in gastrointestinal pH in combination with the enzymatic activity of the microbiota as independent but complementary release mechanisms to guarantee site-specific release.

Featured News

Intract Pharma Limited and Neopharma Japan Enter into a Collaboration to Develop a Novel Treatment for Gastrointestinal Diseases using Intract’s Proprietary Drug Delivery Technologies

Intract Pharma announces market launch of a first Phloral® colon-targeting product

Intract Awarded Innovate UK Grant to Manufacture an Oral Antibody Formulation Using its Soteria® Technology